GS3 Development of a Technology Platform for Novel Drug Discovery Aimed at Regulating Biological Function GS3-1 Artificial transcription factors based on multi-zinc finger motifs GS3-2 Enhancement of ADCC activity by tandem Fc multimerization GS3-3 Application of bioactive mutant TNF-α to mucosal vaccine adjuvant GS3-4 Preparation of chimeric monoclonal antibodies against tumor-specific light chains of CD98 amino-acid transporters GS3-5 Creation of TNF receptor I-specific antagonist, and its therapeutic efficacy for autoimmune disease